Benzene-Associated
The acute toxicity of benzene is manifested by its effect on the central nervous system (anesthetic action) and skin and mucous membrane irritations. Individuals exposed to very high concentrations of benzene (usually > 1,000 ppm) shows signs of central nervous system disorders, giddiness, euphoria, nausea and headache'). If workers get used to the aromatic odor of benzene, they can work for few hours in the presence of benzene at concentrations between 500 and 1,000 ppm. In general, an 8-h exposure to around 100 ppm of benzene does not induce distinct acute toxicity.
Long-term exposure to a high concentration of benzene induces hemopoietic toxicity (myelotoxicity)').
Chronic benzene exposure can induce a spectrum of pathological states ranging from mild leucopenia or anemia to pancytopenia (depression of the levels of all circulating blood cell types), depending on the exposure level (concentration X duration) and individual susceptibility. Serious intoxication presents a feature of aplastic anemia, characterized by a marked decrease in hemopoietic function of the bone marrow. Clinically, anemia and bleeding tendencies (e.g., bleeding from the nose and gums, subcutaneous bleeding, and hypermenstruation) are typical symptoms.
Because benzene has been identified as a human carcinogen (leukomogen), the use of benzene in industries as a solvent has been strictly controlled and measures to decrease benzene exposure in workplaces have been introduced in most countries. Nowadays, concerns with benzene are centered on whether long-term, low-level exposure to benzene is a cause of leukemia not only in industrial workers but also in the general population. This review focuses upon the relationship between benzene and leukemia. 
Metabolism of benzene in relation to its toxicity
Benzene myelotoxicity is not induced by benzene itself; its metabolic intermediates are the cause (Fig. 1) . Cytochrome P-4502E1 (CYP2E1) is a major catalyst of the oxidation of benzene in the liver (the first step of benzene metabolism) in humans2' 3), rats3-9), mice3 ' 8) , and in rabbits4 ' 10) Benzene epoxide was once suspected as a toxic intermediate, but recent findings indicate that catechol, benzoquinone and hydroquinone may be the cause"-16) Erexson et al. 12) exposed human peripheral T-lymphocytes to benzene and its metabolic intermediates (phenol, catechol, 1,2,4-benzenetriol, hydroquinone, 1,4 -benzoquinone and t, t-muconic acid) and observed the frequency of sister chromatid exchanges (SCE), the mitotic index and the cell cycle kinetics. The SCE frequency was increased dose-dependently by benzene, phenol, 1,2,4-benzenetriol and hydroquinone, while the mitotic index was decreased and the cell cycle kinetics was inhibited. The effects of benzene and its metabolites, when compared in terms of SCE induction, were in the order of catechol > 1,4-benzoquinone > hydroquinone > 1,2,4-benzenetriol > phenol > benzene. t, t-Muconic acid did not show any effect.
Although benzene is metabolized mainly in the liver, its main toxicity appears in the bone marrow, and thus the relation between metabolism and toxicity is complex. At present, most researchers support the hypothesis that metabolic intermediates such as phenol, catechol and hydroquinone produced in the liver are transported to the bone marrow where they are metabolically activated to ultimate toxic intermediates l' ' 18) . The secondary activation in the bone marrow apparently plays an important role in the development of myelotoxicity including carcinogenicity, but the final steps have not yet been identified. While t, t-muconaldehyde, catechol, 1,4-benzoquinone and hydroquinone are gathering attention recently, some reports [19] [20] [21] suggest the importance of hydroquinone and 1,4-benzoquinone among these.
Yager et al. 19 ) examined the induction of chromosomal aberrations in human lymphocytes by metabolic intermediates of benzene (phenol, catechol, hydroquinone and 1,4-benzoquinone) in a micronucleus test. Using anti-kinetochore antibody, the cells were divided into those with the micronuclei containing whole chromosomes (kinetochorepositive) and those with the micronuclei having a part 'of chromosomes (kinetochore negative). All of the metabolic intermediates of benzene induced micronuclei in the lymphocytes. While the induction of micronuclei by phenol, catechol and 1,4-benzoquinone was 2-to 5-fold, that by hydroquinone was 11-fold. Since numerous micronuclei and an increased number of kinetochore-positive micronuclei were induced by low concentrations of hydroquinone, Yager et al. considered that hydroquinone played a major part in the induction of chromosomal aberrations in human lymphocytes. Glatt et al. 20) reported an experimental result indicating that the mutagenicity of hydroquinone and 1,4-benzoquinone in V79 Chinese hamster cells was ;tronger than that of any other metabolic intermediates. Further, Post et al.21 ) demonstrated that phenol was oxidized by macrophage peroxidase to a metabolic intermediate which covalently bound to -ellular macromolecules. They presumed this intermediate to be either hydroquinone or benzoquinone :)n the basis of their stronger effects on RNA synthesis.
Interaction among benzene metabolites
While a single metabolic intermediate of benzene (phenol, catechol, hydroquinone, 1,4-benzoquinone :)r t, t-muconaldehyde) induces micronuclei and SCE Ln human lymphocytes, myelotoxicity caused by Benzene does not occur in vivo by any of the intermediates alone. However, when phenol and hyIroquinone were administered simultaneously to B6C3Fi mice, inhibition of bone marrow function occurred, which was not seen by the single adminis-:ration of any other compounds 22). To elucidate :his phenomenon, Smith et al. 23 ) examined the mutual interaction between phenol and hydroquinone metabolism and found that phenol greatly ac-;elerated the oxidation of hydroquinone to 1,4-)enzoquinone by myeloperoxidase. To further elu-;idate the mutual interaction, Subrahmanyam et x1.24) administered [14C] phenol and [14C] hydroquilone to mice either independently or in mixture and )bserved their covalent binding to the macromolemules in blood, bone marrow, liver and kidneys. the result was that phenol promoted the covalent )finding of hydroquinone or its metabolites in blood mnd bone marrow. These authors supported the iiew of Smith et al., proposing that the interaction )etween hydroquinone and phenol on myelotoxicity was due to an acceleration of myeloperoxidaselependent metabolism of hydroquinone to 1,4-)enzoquinone by phenol.
A synergistic interaction of benzene metabolites ias also been confirmed in culture cells. Robertson ?t al.25 examined the appearance of micronuclei in ,ultured human lymphocytes using phenol, catechol find hydroquinone and found that a combination of iydroquinone with catechol increased the appearance of micronuclei synergistically. This also sup-)orts the finding of Smith et al. 23 ) that the simultaieous administration of benzene's phenolic metaboites caused myelotoxicity similar to that caused by )enzene itself. Based on the above reports, the prevailing working hypothesis is that the metabolic pathway from hydroquinone to benzoquinone with production of a semiquinone radical is associated with benzene myelotoxicity. Several intermediate metabolites of benzene seem to be involved synergistically in the myelotoxicity. The formation of oxygen radicals26) or DNA adducts27), or the inhibition of DNA polymerase2S) has also been postulated as the underlying mechanism of the hydroquinone-benzoquinone pathway-induced chromosomal aberrations.
Oliveira and Kalf29) observed the effect of hydroquinone on the differentiation of human promyelocytes (HL-60) into granulocytes/phagocytes. Hydroquinone specifically inhibited the differentiation of HL-60 cells to phagocytes. The authors suggested that benzene myelotoxicity could be explained in part by the inhibition of differentiation of stem cells to phagocytes by hydroquinone, because phagocytes take part in the regulation of hematopoietic function by producing interleukin (IL)-l.
Phagocytes and fibroblasts, which are interstitial cells of the bone marrow, are closely associated with the proliferation of myeloid and lymphatic cells21, 30)For example, phagocytes in the bone marrow have high peroxidase activity and metabolize hydroquinone to 1,4-benzoquinone, while the activity of DT-diaphorase, a reductase which inactivates the benzoquinone, is low 31). Twerdok et x1.32) also reported that DT-diaphorase plays an important role in the defense system against the myelotoxicity of 1,4-benzoquinone. Ganousis et al. 33 ) measured the activities of enzymes associated with the activation and inactivation of hydroquinone/benzoquinone (e.g., peroxidase, glutathione Stransferase, UDP-glucuronyl transferase and DTdiaphorase) in the bone marrow interstitial cells (phagocytes and fibroblasts) of B6C3F1 mice. They found that the glutathione S-transferase and DT-diaphorase activity levels were high in fibroblasts, while the activity levels of peroxidase and UDP-glucuronyl transferase were high in phagocytes. Although the exact nature of the peroxidase involved in the hydroquinone -benzoquinone reaction was not clearly demonstrated, apparently the enzyme was not prostaglandin H synthase, as suggested earlier by Schlosser et al.34) , because the reaction progressed with peroxide but not with arachidonic acid. The report of Ganousis et al. includes the interesting result that the activation of hydroquinone to benzoquinone was greatly augmented by the simultaneous addition of catechol.
Guy et al. 35 ) administered 1,4-benzoquinone, t, tmuconaldehyde and hydroquinone intraperitoneally to Swiss albino mice singly or in combinations to observe their effects on 59Fe incorporation into erythrocytes. While a combination of hydroquinone and t, t-muconaldehyde showed an additive effect, 1,4-benzoquinone and t, t-muconaldehyde acted competitively when administered together. These results suggest that benzene myelotoxicity is caused not by one metabolic intermediate but rather by more than one metabolite, each acting at different action (target) sites.
Phenol, the main metabolite of benzene, is metabolized to hydroquinone by cytochrome P-450 enzymes in the liver. Subrahmanyam et al. 36 ) demonstrated that phenol was biotransformed to hydroquinone in the presence of a superoxide anion radical generating system (hypoxanthine-xanthine oxidase), using myeloperoxidase isolated from human polymorphonuclear leukocytes.
Furthermore, they observed that singlet oxygen (102) was associated with phenol -~, hydroquinone transformation rather than H202 or hydroxyl radical (HO-, using various scavengers 37). The finding that phenol is transformed to hydroquinone by myelooxidase present in the bone marrow and peripheral leukocytes may explain how hydroquinone accumulates in the bone marrow.
Glatt and Witz38) examined the mutagenicity of t, t-muconaldehyde (MALD) and t, t-muconic acid (MA) to Chinese hamster V79 cells and a Salmonella system. MALD was weakly mutagenic to Salmonella typhymurium, while MA did not show mutagenicity to any strain of Salmonella. Although MALD exhibited strong cytotoxicity to both Salmonella bacteria and V79 cells, the cytotoxicity of MA was less than 1/100 that of MALD. Thus, the oxidation of MALD to MA is considered to be a detoxification process. MALD was mutagenic to the V79 cell line, but its dose-effect relationship showed hyperlinearity and its mutagenicity was not demonstrated at a low concentration. The mutagenicity of MALD to V79 cells was weak compared with that of 1,4-benzoquinone or hydroquinone. From these findings, benzene mutagenicity seems to be more closely associated with the hydroxylation of benzene ring (hydroquinone, benzoquinone, etc.) rather than with the cleavage of the ring (MALD and MA).
Species difference in benzene metabolism
A species difference was observed in the metabolism of benzene : mice produced active metabolic intermediates to a greater extent than did rats39' 4°). Sabourin et al. 41 ) compared benzene metabolism between F344/N rats and B6C3Fi mice repeatedly exposed to 600 ppm benzene (6 h/d, 5 d/wk, 3 wk).
Benzene metabolism was evaluated by the urinary excretion of metabolic intermediates, formation of hemoglobin adducts and appearance of micronuclei in erythrocytes. No effect of cytochrome P-450 induction by repeated exposure to benzene on the metabolism was observed in any parameter. The only change induced by the repeated exposure was that glucuronate conjugation became dominant in rats, in contrast to sulfate conjugation in mice. Comparison between the rats and mice revealed that the formation of hemoglobin adducts was similar, despite the finding that benzene metabolism in the mice was 3 times higher than that in the rats. Benzene exposure for one week significantly increased the appearance of micronucleated polychromatic erythrocytes in the mice, but not in the rats. However, the number of micronucleated erythrocytes in the mice did not increase further by additional benzene exposure.
Benzene metabolism according to exposure concentration
According to the results of recent studies, exposure concentration seems to greatly affect the metabolic pathway of benzene. The formation rate of active metabolites was higher at low than at high exposure concentrations42 ' 43) Medinsky et al. 44 ) simulated benzene metabolism in men using a physiologically-based toxicokinetic model on the basis of the data obtained from experiments with mice. In the exposure to benzene at concentrations lower than 10 ppm, the rate of metabolism was directly proportional to the concentration. Moreover, the main metabolites at such a low exposure level were hydroquinone conjugates, which are closely related to benzene toxicity. However, as the exposure level was raised, the formation of phenyl conjugates, which is a detoxification pathway, became the major metabolic route. Assuming that benzene toxicity is associated with hydroquinone formation, a linear extrapolation of the results of toxicity tests at high exposure levels would result in underestimation of the effect. ' 46) reported that 51 cases of leukemia occurred in shoemakers exposed mainly to benzene between 1967 and 1983. The incidence (13 per 100,000) was significantly higher than that of the general population in Turkey, i.e., 2.5-3 per 100,000. However, the major drawback of this study is the lack of information related to the exposure level of benzene. In Wong's stud Y47), the relative risk cannot be calculated because there was no death due to leukemia in the control group. In addition, the exposure group had no case of acute myeloic leukemia, which is known to be strongly associated with benzene, among the cases of death due to leukemia. While Ott et al. 48 ) examined three cases of leukemia occurring among 594 workers exposed to benzene in 33 years (1940-1973) , those exposed to benzene were also exposed to various other chemical compounds.
In comparison to these studies, the Pliofilm cohort of Rinsky et al. 51 ) is considered the best at present to assess the risk related to benzene exposure in that the exposure level was relatively well estimated and the cohort subjects were not exposed much to chemicals other than benzene. This study will be mentioned in detail later in the section of risk assessment.
Yin et al. 53, 54) reported an epidemiological study related to benzene leukemia carried out for the first time in China. Although the use of benzene in industries has been strictly controlled worldwide, benzene was used in various factories in China in 1970s or before 55). The study of Yin et al. is a retrospective cohort study conducted in 233 factories using benzene and 83 control factories in 12 cities of China. The exposure group consisted of 28,460 workers (178,556 person-years between 1972 and 1981), and the control group 28,257 workers (199,201 person-years). The exposure group had 30 cases of leukemia (25 dead and 5 alive), and the control group four cases (all dead). The majority (76.6%) of leukemia cases (myelocytic 13, monocytic 4, myelo-monocytic 2, lymphocytic 3, and erythroblastic 1) occurring in the exposure group were of the acute type. The benzene level in the air to which the patients had been exposed was in the range between 10 and 1,000 mg/m3 (mostly between 50 and 500 mg/m3).
The mortality rate from leukemia was 14/100,000 in the exposure group and 2/100,000 in the control group. The standardized mortality ratio (SMR) adjusted by the control group was 5.74 (p < 0.01 by U test).
The mortality rate from cancer as a whole in the benzene exposure group (123.2/100,000 personyears) was higher than that in the control group (54.7/100,000 person-years) and, in the male exposure group, not only the number of deaths from leukemia (SMR 5.74) but also that from lung cancer (2.31) were high. In contrast, leukemia was the only malignant tumor with a higher mortality rate in the female benzene exposure group than that in the control group. This study supported the results of animal experiments to be described later, where benzene induced tumors in multiple organs. In this connection, among the recent epidemiological studies, there is a report56) suggesting that benzene is related not only to acute myeloid leukemia (specifically, nonlymphatic leukemia) but also to tumors of the lymphatic tissues including multiple myeloma, lymphoma and lymphocytic leukemia. While the studies of Yin et al. included a large number of workers exposed to benzene, its major drawback may be the lack of accurate information on the level of benzene exposure.
Benzene carcinogenicity in animal experiments
While the benzene-induced malignant tumor usually observed in humans is acute myeloic leukemia (AML), benzene has induced a variety of tumors in experimental animals. Based on the carcinogenicity study in progress in the Bologna Cancer Institute since 1976, Maltoni et al. 57) reported that benzene was a multipotential carcinogen, showing tumorigenicity in various tissues including Zymbal gland, oral cavity, liver and mammary gland in rats. According to the reports of Huff et al. 58, 59) , benzene induced tumors in various tissues including Zymbal gland (both sexes), oral cavity (both sexes) and skin (male only) in F344/N rats, and Zymbal gland (both sexes), lung (both sexes), Haderian gland (male), perpetual gland (male), mammary gland (female) and ovary (female) in B6C3F1 mice, supporting the above study by Maltoni et al.
These results demonstrate that although the relation between benzene and tumors in tissues other than hematopoietic tissues is unclear in humans, the majority of tumors caused by benzene in experimental animals are tumors other than leukemia, suggesting that the target tissues of benzene differ between humans and rodents. Except for two studies by Goldstein et al.60) and Cronkite et al. 61) , all studies attempting to induce AML in rodents (rats and mice) by benzene have failed.
Snyder et a1.62) of the New York University Institute of Environmental Medicine were the first to report a case of leukemia induced by benzene in animal experiments. They exposed C57B1/6J mice to 300 ppm benzene for 6 h/d, 5 d/wk for life and detected thymic lymphoma in 8 of 40 animals.
Goldstein et al.60) reported four cases of bone marrow tumors in rodents probably induced by benzene. They observed the development of one case of myelogenous leukemia, one case of acute myeloblastic leukemia and one case of granulocytic bone marrow hyperplasia out of 40 CD-1 mice exposed to 300 ppm benzene for 6 h/d, 5 d/wk for life. They also reported one case of myeloid leukemia out of 40 Sprague-Dawley rats exposed to 100 ppm benzene under a similar experimental schedule. The authors suggested that, although the incidence was not significantly different from that in the control animals, the myeloid lesions were caused by benzene because there had been no report of spontaneous myeloid leukemia occurrence in these two species before. The report of Goldstein et al. is considered the first report suggesting the association of benzene exposure with the development of myeloid leukemia in rodents.
Cronkite et al. 63) exposed female C57B1/6 mice to 300 ppm benzene for 6 h/d, 5 d/wk for 16 weeks and continued observation throughout life thereafter. While only one of the 88 control group animals died in the control group, 10 of the 90 animals in the exposure group died, by 64 weeks after the start of the study. Thymic lymphoma was detected in six of the 10 dead mice in the exposure group and unspecified lymphoma in the other two. Another animal in the moribund state was sacrificed and confirmed not to have leukemia. The cause of death of the remaining animal that died could not be specified because a part of its body was cannibalized and tissue liquefaction had already started. The cause of death of the control animal was confirmed to be neither lymphoma nor leukemia. These results indicated that benzene could induce lymphoma in C57B1/6 mice. This study differed from others in that the animals were exposed to benzene for only 16 weeks and the rest of life was left in the non-exposed state. However, it should be emphasized that the C57B1/6 mice used is liable to develop leukemia by nature. In the experiment by Snyder et al. 62) mentioned above, leukemia developed in C57B1/6 mice but did not occur in AKR/J mice.
In a later study, Cronkite et al.61) exposed male CBA/Ca mice to 10, 25, 100, 300, 400 or 3,000 ppm benzene for 6 h/d, 5 d/wk for up to 16 weeks, and observed the myelotoxicity. Two-week exposure to 10 ppm benzene caused no hematological effect, but two-week exposure to 25 ppm benzene significantly decreased the number of lymphocytes in the peripheral blood. Exposure to 100, 300 or 400 ppm benzene induced a dose-dependent decrease in the number of lymphocytes, myelocytes and spleen colony-forming units (CFU-S) in the bone marrow. A marked decrease in lymphocytes and a decrease in CFU-S in the bone marrow occurred by exposure to 300 ppm benzene for two, four, eight and 16 weeks. The damage in the bone marrow caused by exposure to 3,000 ppm benzene for 8 days was less than that caused by exposure to 300 ppm for 80 days. When CBA/Ca mice were exposed to 300 ppm benzene for 6 h/d, 5 d/wk for 16 weeks, myelogenous tumor (leukemia) developed in male mice. However, Farris et al. 64) , in a study based on the experimental procedure employed by Cronkite et al., did not observe the development of myeloid leukemia due to benzene in CBA/Ca mice.
Farris et al. 64 ) conducted a carcinogenicity test of benzene using CBA/Ca mice to examine benzeneinduced myelogenous (granulocytic) leukemia in this strain of mouse. An exposure group consisting of 150 CBA/Ca mice was exposed to 300 ppm of benzene for 6 h/d, 5 d/wk for 16 weeks, and the same number of mice (control group) inhaled air containing no benzene for the same period of time. After 16-week exposure, the animals were kept under ordinary conditions, and dead or moribund mice were autopsied to confirm the cause of death. Observation was continued until the survival rate of the exposure group had declined to 20% (22 months after the start of exposure). At the end of the observation period, blood and bone marrow of the 24 surviving mice of the exposure group and those of 24 randomly chosen control group mice were histologically examined. At the time when the survival rate in the exposure group was 20%, 60% of the control group animals were alive (p < 0.01). The major cause of death in the exposure group during the observation period was malignant lymphoma accompanying metastasis. Throughout the observation period, malignant lymphoma occurred in 14 out of 118 animals (12%) in the exposure group and in two of 119 (2%) in the control group (p < 0.002). Preputic cell carcinoma developed in 71 mice (60%) in the exposure group while it did not occur in the control group. The incidence of lung adenoma was also significantly higher in the exposure group (36%) than in the control group (14%).
The incidence of Zymbal gland carcinoma (11% vs. 1%) and that of squamous cell carcinoma in the anterior stomach (7% vs. 0%) were also higher in the exposure group, but the difference was not significantly different. No significant difference was observed in the incidence of Haderian gland adenoma (6% vs. 5%).
A striking result of this carcinogenicity study is that there was no occurrence of granulocytic leukemia in CBA/Ca mice, even though the investigators conducted the study with the same protocol as that of Cronkite et aL61), who reported the leukemia caused by benzene. In the study of Farris et al. 64 ), hyperplasia of myelogranulocytes was seen at a high frequency in the exposed group (36% vs. 8% in the control group). Farris et al. suggested that this hyperplasia was caused not by benzene, but by a reactive change produced by the vulnerability of both preputic adenoma and Zymbal gland adenoma to become purulent ulcers.
Genotoxicity (Mutagenicity)
While most mutagenicity tests of benzene using bacteria, drosophila and mammal cells were negative65 67), exposure to benzene induces chromosomal aberrations in the bone marrow cells or peripheral lymphocytes of animals and humans. In particular, benzene is known to increase the incidence of SCE and micronuclei.
Experimental results have indicated that benzene induces the chromosomal changes at relatively low doses.
Styles and Richardson6S) exposed 6-8 week-old Wistar rats to 1, 10, 100 or 1,000 ppm of benzene for six hours. The frequency of chromosomal aberrations increased significantly in rats exposed to 100 and 1,000 ppm benzene. Although no significant increase was observed in rats exposed to 1 or 10 ppm benzene, the incidence rate of chromosomal aberrations increased with the level of benzene exposure ; 0.25% at 0 ppm, 0.41% at 1 ppm, 0.91% at 10 ppm, 1.23% at 100 ppm and 4.49% at 1,000 ppm, a finding which indicated a dose-effect relationship between the exposure dose and the incidence of chromosomal aberrations (excluding gaps).
While this study has found that a single exposure to benzene resulted in chromosomal damage in rats, apparently contradictory experimental results have been documented in literature 69) : the same exposure concentration of benzene induced a higher incidence of chromosomal aberrations in a group exposed for two hours than in a group exposed for six hours, and the aberrations occurring from a single exposure did not appear after repeated exposure. Thus, the chromosomal aberrations observed after a single exposure of animals to benzene needs further careful evaluation.
By exposing CD-1 mice to benzene (0, 40, 100 or 1,000 ppb) for 22 h/d, 7 d/wk for 6 weeks, Ward et al. 70 ) observed the variation in hypoxanthineguanine-phosphoribosyl transferase (hprt) in the splenic lymphocytes.
Variant cells were distinguished by observing 3H-thymidine uptake in the presence of 6-thioguanine by autoradiography. The frequency of variant cells (Vf) in female mice was 7.2 X 10-6 at 0 ppb, 29.2 X 10-6 at 40 ppb, 62.5 X 10-6 at 100 ppb and 25.0 X 10-' at 1,000 ppb. The Vf was higher in female mice than in males, but the tendency was similar in both sexes. Although it is not clear why frequency of hprt variation increased at 100 ppb and decreased at 1,000 ppb, a similar tendency was also noted in chromosomal aberrations in splenic lymphocytes in the same animals. It is interesting that the mutagenicity test was positive at a concentration as low as 100 ppb, but it is necessary to take into account the fact that the animals in this study were exposed to benzene for 22 h a day, with only a two-hour break from exposure per day.
Benzene metabolites such as hydroquinone, catechol and 1,2,4-benzenetriol form DNA adducts in HL-60 cells, mouse bone marrow macrophages, and human bone marrow cells71 73). In contrast to these in vitro findings, the evidence for the formation of DNA adducts in animals treated with benzene has been contradictory.
32P-postlabeling studies have demonstrated DNA adduct formation in the liver of New Zealand rabbits74) and in the bone marrow of B6C3Fi mice 75) treated with benzene ; however, Reddy et al. [76] [77] [78] were unable to detect the formation of DNA adducts in various tissues of either Sprague-Dawley rats or B6C3Fi mice administered benzene or its hydroxylated metabolites.
Lee et al. 79) identified p-benzoquinone (BQ) and 1,2,4-benzenetriol (BT) as toxic metabolites of benzene on the basis of their inhibitory effect on DNA synthesis. Later, Lee and Garner" investigated the capability of benzene and the two metabolites to induce DNA strand breaks was in either the in vivo or the in vitro system by comparing the DNA elution rate on a fine membrane filter at alkaline pH. In the in vitro system where bone marrow cells were reacted with test chemicals for 60 min, both BQ and BT induced a dose-related increase in alkalilabile DNA single-strand breaks (SSBs) of bone marrow cells. However, when glutathione (350 ,u g/ ml) was added to the same reaction system, the DNA damaging effect of BQ (24 ,uM) and BT (24 ,u M) was blocked by 100 and 53%, respectively. Catalase (130 units/ml) completely blocked the DNA damaging effect of BT, while no protection was afforded with BQ. Consistent with these observations, no induction of alkali-labile DNA SSBs was observed in the in vivo system by an anesthetic dose of benzene (1,760 mg/kg, ip or po) at 1-, 24-, and 36-h postadministration in both male and female ICR mice. From these results Lee and Garner concluded that benzene exposure would not induce direct DNA strand breaks in vivo under realistic work-related or accidental exposure conditions and also that caution should be exercised in the interpretation of in vitro data for whole-body toxicity evaluation.
Au et al. 81 ) warned that risk assessment in humans on the basis of experimental studies employing high levels of exposure might result in misleading conclusions. They subjected mice to an inhaled mixture of benzene, chloroprene, epichlorohydrin and xylene and observed the chromosomal aberrations in peripheral lymphocytes. The results demonstrated that the frequency of chromosomal aberrations was higher at low levels of exposure (0.1-1.0 ppm of each compound) than that at a high level of exposure (10 ppm). The explanation suggested by Au et alL for this result was that glutathione-S-transferase, which counteracts the toxicity, could be induced by high levels of exposure.
Many surveys have been conducted to clarify the effect of benzene exposure on chromosomes in peripheral lymphocytes in humans. As mentioned above, although chromosomal aberrations have been confirmed to be induced by relatively low doses of benzene in animal experiments, similar changes have not been proven to occur in humans.
Sarto et al. 82) examined the frequency of SCE in the peripheral lymphocytes of 22 workers in the chemical industry manufacturing benzene from coal tar. These workers were exposed to 0.2-12.4 ppm benzene for 11.4 ± 7.0 years. Workers in neighboring factories where no benzene was used served as the control group. The control subjects were matched the exposure group subjects by sex, age, smoking habit and residential area. The exposure group was divided into a high-exposure group and a low-exposure group according to the benzene concentration in the expired air and urinary excretion of phenol, a metabolite of benzene. The results demonstrated that the SCE frequency, which had no significant difference between the exposure and control groups, was even lower in the high-exposure group than in the low-exposure group.
Clare et aL 83) also examined chromosomal aberrations and SCE in workers exposed to relatively high concentrations of benzene 3 months earlier and reported that chromosomal aberrations due to benzene exposure could not be detected.
In their report, nearly 1,200 gallons of benzene was accidentally leaked during a ship loading, and 10 workers were exposed to benzene. The urinary excretion of phenol in the workers after the accident was quite high. Clare et alL collected venous blood samples from these 10 workers (exposure group) and 11 workers who were engaged in similar jobs but were not exposed to benzene (control group), and examined the chromosomal aberrations in lymphocytes. Lymphocytes were cultured to promote division, and 200 cells in the middle stage of mitosis during a 49-h culture were examined for evaluation of the chromosomal damage, while 30 cells in the second stage of mitosis during a 72-h culture were examined for detection of SCE. The number of cells showing chromosomal aberrations was larger in the control group than in the exposure group, and this tendency was particularly prominent for chromosomes with chromatid gaps. However, all the values were within normal range. A few of the exposed workers showed a slightly higher incidence of SCE, leading to a positive correlation between urinary phenol excretion at the time of exposure and SCE frequency (r=0.55, 0.05 < p < 0.10), but no evidence indicating that the single exposure caused continuous chromosomal damage was obtained.
This indicates that either chromosomal damage was not induced by benzene exposure at such a level (the mean urinary phenol concentration at a short time after exposure was 127.3 mg/l) or that the damage which might have been present at the time of exposure disappeared over the period of 3 months. Thus, chromosomal damage by a single exposure to benzene has not been confirmed in humans, in contrast to the results of animal experiments.
Major et al. 84 ) compared the incidence of chromosomal aberrations (CA), the frequency of SCE and the proliferation rate index (PRI) of the peripheral lymphocytes between workers engaged in the distillation of benzene at petroleum refineries exposed to low doses of benzene (mean concentration, 7.2 mg/m3 or 2.3 ppm) and control workers. While exposure to this low dose of benzene raised the incidence of CA and SCE, it did not affect the PRI. Smoking habit was stratified according to self-statement and serum thiocyanate concentration. No influence of smoking on CA, SCE or PRI was shown. Smoking is known to cause chromosomal changes (SCE in particular), but the changes were not demonstrated in this study.
According to Santos-Mello and Cavalcante85), the incidence of chromosomal aberrations in peripheral lymphocytes was significantly high among the gasoline stand refueling attendants in Rio de Janeiro and Sao Paulo, Brazil, compared to that in the control group. Although this report did not provide the benzene content in the gasoline, the subjects were considered to have inhaled quite a large amount of gasoline vapor, because only a few gasoline stands were equipped with an automatic refueling system in those cities at the time of the survey and the refueling workers were said to judge the filling of a gas tank by sound, by touching their ears to the car's gas tank opening.
Chronic benzene toxicity in relation to carcinogenicity
Whether chronic benzene intoxication is involved in the development of leukemia is of great concern in benzene toxicology.
The epidemiological stud Y53, 54), which Yin et al. carried out in China, indicated a relation between these two pathological states. According to these authors, out of 25 cases of death due to leukemia in the benzene exposure group, 7 had chronic benzene intoxication before developing leukemia. The mortality rate from leukemia in patients with chronic intoxication was 700 /100,000 person-years, a 50-times higher rate than that in the whole exposure group (14/100,000). Based on this observation, Yin et al. suggested that prevention of chronic benzene intoxication would be effective for prevention of benzene leukemia. However, it is uncertain whether or not chronic benzene intoxication (that is, exposure to high concentrations of benzene) is a prerequisite for the development of leukemia.
Ruiz et a1.86) reported an interesting finding in relation to hypoplasia of bone marrow due to chronic exposure to benzene. Workers at a steelworks in Sao Paulo were exposed to high concentrations (8-2,000 ppm) of benzene for a long period because of a leak from the gas pipe of a smelting furnace. The jobs of 152 workers were changed due to abnormalities observed in hematological examination (mostly neutropenia). Bone marrow samples were collected from these workers and examined histologically. This examination was conducted for the workers whose peripheral neutrophil counts were less than 2,000/mm3, with the erythrocyte sedimentation rate and the reticulocyte count within the normal ranges. Their feces were tested for intestinal parasites three times, and only those whose fecal tests were negative were included in the study. Sixty percent of the subjects complained of general malaise including asthenia, myalgia, drowsiness and vertigo.
Fifty-four percent of the subjects had white blood cell counts less than 4,000/mm3 in the peripheral blood, but anemia (hemoglobin content < 13 g/100 ml) was detected only in 9%, and only one case showed thrombocytopenia (< 150,000/ mm 3). However, eosinophilia (> 500/mm 3) was observed in 27% of the subjects. A typical change in bone marrow histology was hypoplasia of hemopoietic tissue ; this change was observed in 82% of the subjects.
Although most of the hypoplasia cases (87%) were due to a decrease in the precursor cells of granulocytes, eosinophilia in the bone marrow was observed in 71% of the cases. Ruiz et al. stated that eosinophilia was one of the characteristic symptoms of chronic benzene intoxication, since the subjects presented no allergic symptoms and were negative in parasite tests. It is not clear at present whether the changes seen in the peripheral blood and the bone marrow of the subjects with chronic benzene intoxication were caused by benzene alone or by a combination of benzene with other factors.
Biological monitoring of benzene exposure
In the likely event of lowering the occupational exposure limit of benzene from 10 ppm to 1 ppm or lower, the measurement of urinary phenol content will be useless for monitoring benzene exposure. In recent years, attempts have been made to use urinary concentrations of benzene metabolites other than phenol, t, t-muconic acid (MA) or Sphenylmercapturic acid (S-PMA), as markers of benzene exposure.
Inoue et a1.87) were the first to use the urinary MA concentration for the biomonitoring of occupational exposure to benzene. Ducos et al. 88 ) reported a method for detecting MA in urine as low as 0.05-0.1 mg/1 by high pressure liquid chromatography (HPLC) using a simple clean-up procedure. According Ducos et al., MA rarely exceeds 0.5 mg/1 in the urine of non-exposed persons, and benzene exposure of a few ppm can be distinguished by its measurement. An ordinary intake of sorbic acid, a food additive which is a precursor of MA, will affect the biomonitoring only insignificantly. Bechtold et al. 89) proposed a method for measuring urinary MA by gas chromatography-mass spectrometry (GC-MS) after trimethylsilyl esterification. This method is claimed to be sensitive and applicable to benzene exposure at the 1 ppm level.
Stommel et a1.90) exposed rats to benzene at levels of 1 to 500 ppm and assayed the urinary concentration of S-PMA using amino acid analysis. A significant correlation existed between S-PMA and benzene exposure level. In order to confirm the possibility of monitoring benzene exposure by measuring urinary S-PMA, they determined the S-PMA concentrations in the urine of workers occupationally exposed to benzene. In workers who were exposed to benzene at the maximum level of 0.15 ppm for 8 h, the concentration of 12.0±16.0 before exposure increased to 48.5 ± 64.5 ,u g/g creatinine at the end of work. In workers exposed to 1.13 ppm benzene for 12 h, the pre-exposure concentration of 25.1 ± 25.1 increased to 70.9 ± 109.2 ,ug/g creatinine. No significant change was observed in urinary phenol at these low levels of exposure. Urinary S-PMA may be useful as a marker for benzene exposure at levels below 1 ppm, but its complicated measurement method remains a problem.
Bechtold et al. 91 ) measured a hemoglobin adduct with benzene oxide, S-phenylcysteine (SPC), by GC-MS, and examined its usefulness as a marker of benzene exposure.
SPC was detected dosedependently in rats and mice exposed to benzene. However, SPC was not detected in workers exposed to 28 ppm benzene for 8 h/d, 5 d/wk.
Later, Bechtold et al. 92) reported a method for measuring SPC as an albumin adduct by modifying the purification method of blood albumin. The SPC in albumin was detected in workers exposed to benzene. Albumin SPC levels in 7 out of 9 subjects who were not occupationally exposed to benzene were below the detection limit (0.1 pmol SPC/mg albumin), suggesting that albumin SPC may be a promising biomarker for benzene exposure at low levels.
Bechtold and Henderson93) compared the usefulness as a biomarkers of benzene exposure between urinary MA and albumin SPC. MA concentrations in the urine of workers exposed to 4.4 ppm benzene for 8 h (n = 8) and that of control subjects (n = 5 ) were 6.2±3.1 and 0.27±0.21,ug/g creatinine (p< 0.005 ), respectively, and the minimum value in the exposed group exceeded the maximum value in the control group. A regression line between albumin SPC and benzene exposure levels (0-23 ppm) had a slope of 0.044±0.008 (pmol/mg albumin vs. ppm) with an intercept of 0.135±0.095 pmol/mg albumin. From these results, Bechtold and Henderson concluded that urinary MA may be one of the most useful biomarkers for occupational exposure to benzene. MA can probably distinguish the exposure at 1 ppm. However, since benzene exposure in the general environment requires a biomarker for a long-standing exposure, albumin SPC (half life, 20 days) may be a promising biomarker for the general population's benzene exposure. The ACGIH (American Conference of Governmental Industrial Hygienists )98) changed its carcinogenicity classification of benzene from A2 (suspected human carcinogen) to Al (confirmed human carcinogen) in May of 1990 and proposed to reduce its TLV for benzene from 10 ppm (32 mg /m3) to 0.1 ppm (0.3 mg/m) . This proposal was based on the risk assessment of Rinsky et al. 51 ) for benzene-induced leukemia. Although this proposal was to be formal after one-year discussion, an ACGIH booklet of 1994-1995 TLVs noted that the TLV of benzene was changed to 0.3 ppm (0.96 mg/ m3), putting off a final decision even further").
The study of Rinsky et al. 51) which provided the basis for the ACGIH's TLV revision in 1991 was a survey in which the relation between benzene and leukemia in the Pliofilm cohort was reevaluated. The cumulative benzene exposure level was estimated individually from the record of past environmental measurement and the individual working record. The SMR of leukemia in the whole cohort was 3.37 (95% confidence interval, 1.54-6.41), and that of multiple myeloma was 4.09 (1.10 -10 .47). When the SMR was calculated from the cumulative exposure dose (ppm-year), it was 1.09 for 40 ppm-year or lower, 3.22 for 40-100 ppmyear, 11.86 for 200-399 ppm-year and 66.37 for 400 ppm-year and higher. A logistic regression analysis of the dose-response relation revealed that the lowering of the benzene exposure level would exponentially reduce the risk of death from leukemia.
According to the study of Rinsky et al., the risk (odds ratio) of, dying from leukemia by 40-year benzene exposure was 154.5 (95% confidence interval, 3.1-7785) at 10 ppm, 1.7 (1.1-2.5) at 1 ppm and almost equal to the background risk (1.05; 1.01 -1 .09) at 0.1 ppm. Thus, this report indicated a risk of death from leukemia due to occupational exposure to benzene at 1 ppm.
This benzene-leukemia risk assessment by Rinsky et a1.51) eliminated the ambiguity in the doseresponse relation in the past Pliofilm studies. In spite of the criticism that Rinsky et al. overestimated the risk of benzene-induced leukemia, the report was epoch-making in that it suggested a pos- If the observed and predicted probabilities of leukemia are examined, however, the data are seen to be polarized into three areas, with the response at lower levels being relatively flat.
Thus, in the risk assessment of Rinsky et al., it is the three highest exposure cases that drive the model. When using a conditional logistic regression to predict the probability of leukemia at a given level of exposure, with the three cases included, the model was significant (x2 = 13.3, p<0.01); after removal of the three cases (and their control), however, the model was not significant (x2 = 1.4, p=0.23).
Furthermore, the estimates of exposure as highlighted in the study were considered to be an underestimate, and underestimation of exposure would increase the predicted risk at any given exposure. A further confusing factor is that multiple myeloma was the cause of death in four members of the Rinsky cohort of benzene workers, three of the four were among the group with the lowest cumulative exposure to benzene (< 40 ppm-years), and all four required an exceptionally long latency period (>20 years) 56> These two factors indicate a possibility that low cumulative exposure to benzene may result in well differentiated malignancy such as multiple myeloma, whereas higher exposures lead to leukemia 56). This observation confuses even further the risk assessment procedure for occupational and environmental exposure to benzene, for if true it might justify the recent ACGIH proposal for a decrease in the TLV for benzene to 0.1 ppm."
Paustenbach et a1.103), after reexamining the past records and interviewing workers, published their opinion that Rinsky et a1.51) underestimated the level of exposure to benzene in the 1940s and in the early 1950s. According to Paustenbach et al., Rinsky et al. estimated the benzene exposure level as considerably lower (by 25-50%) than the actual level, because they did not take into account 1) short-term high-level exposures, 2) skin exposure, 3) the fact that more than 70% of the workers were working for longer than 40 h per week in the 1940s, and 4) the inefficiency of the respiratory masks used. If these suggestions are justified, the risk assessment by Rinsky et al. will lose its usefulness and the proposal of ACGIH for lowering the TLV of benzene to 0.1 or 0.3 ppm will need to be reevaluated.
The estimation of benzene exposure in the Pliofilm cohort can be summarized as follows. Rinsky et a1.51 ) assumed that workers of the same job category were exposed to the same concentration of benzene unless there was a special reason. In other words, they calculated the risk of benzeneinduced leukemia on the assumption that benzene exposure in 1945 was at the same level as that in 1966. In contrast, Crump and Allen 96) estimated the cumulative exposure and the peak exposure concentration for each worker.
Assuming that the ratio of measured concentration to the TLV in a period during which the data were available was applicable to other periods, they estimated the exposure level in a period without data on the basis of the TLV during the ascertainable period. Thus, their estimated value at the early stage (TLV at that time= 100 ppm) was higher than that estimated by Rinsky et al. 51 . Meanwhile, Paustenbach et al. 103 ) estimated exposure levels considering that unusually long working hours were practiced in the 1940s, the exposure during this period might be underestimated due to the lack of sufficient measurement apparatus, and that considerable amounts of benzene must have been absorbed through the skin under the working conditions at that time. In comparison to the estimates of Paustenbach et al., it may be concluded that those of Rinsky et al. underestimated the benzene exposure in almost all workers, and those of Crump and Allen overestimated the exposure in some job categories and underestimated in others. (Table 1 ). According to this calculation, the excess death rate from leukemia would be 7.9/1,000 and 0.5/1,000 at cumulative benzene exposures of 450 and 45 ppm-years, respectively. Since Brett et alL obtained the results in Table 1 by applying a logistic regression analysis to the data of Rinsky et al. and Crump and Allen, the difference in risk assessment between Rinsky et al. and Crump and Allen is derived from the difference in exposure estimates between the two research groups. Among those, 8 cases were definitely AMML. While a dose-response relationship was observed in all disease groups, the relation was most prominent in AMML. The relationship disappeared when AMML was excluded from either hemopoietic and lymphatic tumors or all leukemia. Thus, it can be said that only AMML was relevant to benzene exposure. Table 2 shows the risk levels of occupational exposure to benzene at 1 ppm calculated from various exposure estimates with different models. According to the results summarized in Table 2 , excess death from leukemia by 45 ppmyear benzene exposure is 1.8-3.6X 10-5 with a nonlinear model, while it is 1.5-3.8 X 10-5 with a linear Table   2 .
Expected number of additional deaths per 1,000 persons from occupational exposure to 1 ppm benzene from age 20 through age 65108) AMML = acute myelocytic or acute monocytic leukemia. 'Methods that provided the best fits to the Pliofilm cohort data. 'Estimated mean number of leukemia deaths over the lifetime of 1 ,000 exposed individuals in excess of an assumed background rate of 7.07 (95% confidence interval). 'All estimates based upon the updated information on all 15 leukemia cases and the 650 controls. `Stated occupational exposure assumed to result from exposure to a concentration of 0.1, 1, 2.5, or 10 ppm for 8 h/d, 5 d/wk, 50 wk/yr. model. Paxton et a1.106, 107) calculated the risk of benzeneinduced leukemia applying a proportional hazards model to a group consisting of 15 cases of death from leukemia among the Pliofilm workers and to a group of 650 control subjects matched to the case group by factory, sex, age and starting year of work (Table 3) Crump and Allen 96) to the data of Pliofilm50) and Dow Chemical48). From this risk assessment, the benzene concentration corresponding to 10-6 excess death from leukemia was about 40 ppt.
The WHO (World Health Organization) Regional Office for Europe'09) calculated the unit risk (1 ,ag/m3) using an average relative risk model with the Pliofilm data reported by Rinsky et also), Infante10), Infante and White' , and White et a1.94) Based on the assumption that the SMR of leukemia in the cohort was 5.60, the background death rate from leukemia was 0.007 for life, the benzene exposure level in the cohort was 30-300 mg/m3, and the period of exposure was 8.5 years, the calculation resulted in a unit risk of 4 X 10-6. The WHO Office also calculated the unit risk as 3.8 X 10-6 with the same model based on the reports of Ott et al. 48 ) and Bond et al. 49) concerning the Dow Chemical cohort by assuming that the SMR of myeloleukemia was 4.40, the background death rate from the leukemia 0.003 for life, the benzene exposure level in the cohort was 100 mg/m3, and the exposure period was 8.5 years. On the basis of these values, the WHO Office proposed a value of 4 X 10 6 as the unit risk for leukemia of benzene in the environmental atmosphere.
The risk assessments of the EPA and WHO may be altered in the future, because the Pliofilm cohort has since been modified by Rinsky Thorslund et a1.112) recommended a quadratic model for the risk assessment of benzene-induced leukemia because the dose-response relationship between benzene and myeloleukemia in the Pliofilm cohort fitted better to a nonlinear model than to a linear model. With this model, they estimated the unit risk (1 ppm) of benzene exposure (24 h/d for 70 years) to be 1.43 X 10-4. By using a linearquadratic model (combination of a quadratic model for high-concentration exposure with a linear model for low-concentration exposure), they also reported 1.00 X 10-3 as the unit risk. Thorslund et alL gave two reasons for using a quadratic model : 1) The Pliofilm data fit well to a quadratic equation, and 2) the mechanism of benzene carcinogenicity is explained better by a two-hit than a one-hit model (two molecules of benzene or its metabolites bind to DNA, inducing leukemia).
Automobile gasoline as a source of benzene exposure While benzene exposure in the workplace is decreasing at present, petroleum containing a few percent of benzene has become an important source of benzene exposure for both industrial workers and the general population. It is worthwhile to discuss automobile gasoline in relation to benzene exposure and its association with benzene-induced leukemia.
Tironi and Hodgkins113) measured benzene concentration at a gasoline refueling stand during the winter (February) and summer (August and September). Benzene content (volume %) in the gasoline was 2.64 in winter and 2.66% in summer. The atmospheric concentration of gasoline in winter was in the range between 0.79 and 734 ppm, and that of benzene measured simultaneously was between 0.01 and 2.88 ppm; the values in summer were 1.08-266 ppm and 0.1-2.30 ppm, respectively. The relation between benzene (Y) and gasoline concentrations (X) was Y=0.0041X+0.027 in winter and Y= 0.00905X-0.0116 in summer. The authors stated that the slower slope during winter was due to the addition of hydrocarbons with low boiling points such as butane and pentane as well as to the low atmospheric temperature. The present TLV of gasoline recommended by the ACGIH is 300 ppm. By applying the above equations to the air at a refueling stand containing 300 ppm gasoline, the benzene concentration is 1.3 ppm in winter and 2.7 ppm in summer.
If the TLV of benzene proposed by ACGIH (0.1 or 0.3 ppm) is realized, the permissible level of gasoline will also have to be lowered. Fool 14) reported that the automobile gasoline sold in Singapore contained 1.8-3.7% benzene, and that benzene exposure derived from gasoline in terms of an 8-h TWA (time-weighted average) concentration amounted to 0.028-0.71 ppm among refueling workers, 0.014-1.7 ppm among automobile repairmen and 0.08-2.37 ppm among drivers of gasoline tank trucks.
The ACGIH's TLV for benzene has a skin notation, in consideration of the potential contribution of skin absorption to the overall exposure. According to Blank and McAuliffe 115, 1.5 ,u 1/h of benzene was absorbed through the skin of an adult working in an environment containing 10 ppm benzene. They also reported that 7.0 ,u l/h of benzene was absorbed by contact of 100 cm2 of skin with petroleum gasoline containing 5% benzene.
In the U.S.A., the modified Clean Air Act was enacted in 1990 to control the release of benzene by technology-based standards and to limit the benzene content in petroleum gasoline to below 1% (v/v) by 1995. Further, the California Air Resources Board has proposed to limit benzene content in gasoline to below 0.8% by 199616).
Gasoline and leukemia
At a meeting on the biological effects of petroleum held in 1991, three papers were presented concerning leukemia among workers engaged in petroleum transport. They suggested excess death due to leukemia, particularly acute myeloic leukemia (AML), among workers engaged in this work. In relation to AML, the SMR given by Rushton"') was 1.21 (25 cases) , that for gasoline tank truck drivers by Schnatter et al.118) 3.35 (5 cases), and that for workers engaged in land transport by Wong et al.119) 1.50 (13 cases), although none of these results showed a statistically significant increase. Whether petroleum exposure is associated with leukemia may depend on the benzene content of the petroleum, but none of the above reports discussed the death from leukemia in relation to benzene content.
Jakobsson et al. 120) examined the incidence of acute myeloid leukemia (AML) with respect to occupation using the Swedish Cancer Environment Registry. Subjects of this survey were 2,308,444 male and female employees aged between 20 and 64 years on the basis of the national census conducted in 1970. Their occupations were classified into 295 categories according to the Nordic Occupational Classification. Examination of the cancer registration in Sweden in 1971-1984 revealed 1,275 cases of AML. The subjects were stratified by sex, age (5-year interval), county (n=24) and degree of urbanization (n=2), and the occupational career was expressed in person-years. In the occupations in which the observed incidence of AML exceeded the expected value, individual information relating to the job category and the job history was obtained by sending a questionnaire to the worker or the surviving family or by interviewing them on telephone. The only occupation in which the observed mortality rate from AML exceeded the expected rate was male petroleum station attendants. There were 9,000 workers classified in this job category, and 10 cases of death from AML were observed, with an SMR of 3.6 (95% confidence interval, 1.7-6.6). The cause of death as AML was confirmed by histopathological examination of bone marrow biopsy specimens. Among those 10 patients with AML, 6 were petrol stand attendants at the time of the 1970 Swedish census. One of the remaining patients was also working at a petrol stand around 1970, and another had been a petrol stand worker and later moved to a rubber industry (liable to benzene exposure). The remaining two patients were handling airplane fuel (benzene content not exceeding 1%) and diesel and light oils (benzene content not exceeding 0.05%), respectively. The period of time that passed between the time of the first occupational handling of petroleum and the time of AML diagnosis was 9 to 36 years (median 16 years), a period which is similar to that of the 3.5 to 37 years reported by Rinsky et aL51 ) .
No components other than benzene are conceivable factors which can explain the excess death from AML among petrol stand attendants. One factor in this issue is the benzene content in gasoline. While gasoline sold in the U.S.A. contains 2% or less benzene, that sold in Europe contains 4-5% benzene65>
Jakobsson et a1.120) stated as follows in relation to gasoline-associated leukemia.
Gasoline sold in Sweden contains as much as 5% benzene and 700 mg of benzene would volatilize in the air during refueling 30 liters of gasoline containing 5% benzene. Benzene content in the exhaust gas during idling of a car engine is high ; the emission of benzene amounts to 10 mg/min.
Since self-service refueling pumps came into general use during the 1970s in Sweden, the exposure of petrol stand attendants to benzene has been lowered compared to that in 1970. In addition, around 1970, many petrol stand attendants and car repairmen had a bad habit of washing oil dirt with gasoline, and this senseless practice (skin absorption as well as inhalation of benzene) might be associated with the development of AML.
A significant correlation between petroleum exposure and AML was also observed in another casecontrol study in Sweden' 21). Excess death due to leukemia including AML was also observed among automobile repairmen in the U.S.A.122). Although a survey conducted in Denmark did not reveal excess death from leukemia (but did from lung cancer) among petrol stand attendants123), case reports of leukemia (particularly AML) developed in workers exposed to petroleum 124, 125) suggest an association between benzene in petroleum and leukemia.
Wolff126) examined the relationship between the incidence of leukemia and lymphoma (1984) (1985) (1986) (1987) (1988) and the rate of automobile possession in 1981 in 22 counties in the United Kingdom.
The result revealed a significant correlation (Spearman's rank correlation coefficient, 0.68) between the incidence of non-Hodgkin's lymphoma (follicular lymphoma) and the rate of automobile possession/1,000 population. Moreover, when the rate of automobile possession was expressed per family, significant correlations were shown with follicular lymphoma (0.66), acute lymphoblastic leukemia (0.44), chronic lym-)hatic leukemia (0.41), total lymphatic tissue proiferation diseases (0.40) and acute myeloic leukenia (0.38). The petroleum engine is an important ource of nonoccupational benzene exposure, but a tasty conclusion should not be made from this tudy since numerous compounds other than ben-;ene are contained in car exhaust gas. However, his study is interesting in that it infers a correlation between the use of automobiles and the incidence of eukemia.
